| 产品名称： | F18 AF1 |
|---|---|
| 商品货号： | TS212192 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified CSF-I. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. CSF-I was purified from medium conditioned by MIA PaCa-2 (ATCC CRL-1420). |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human colony stimulating factor subclass I (CSF-I) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human colony stimulating factor subclass I (CSF-I) |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in pristane primed BALB/c mice |
| Comments： | Animals were immunized with purified CSF-I. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. CSF-I was purified from medium conditioned by MIA PaCa-2 (ATCC CRL-1420). |
| Complete Growth Medium： | Culture Medium: Iscoves modified Dulbeccos medium, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: Twice per week Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp4 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG1 |
| Name of Depositor： | Amgen, Inc. |
| U.S. Patent Number： | |
| References： | Nicolson M. Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1. US Patent 4,504,586 dated Mar 12 1985 . . Hybridoma 2: 137, 1983. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | F18 AF1 |
|---|---|
| 商品货号： | TS212192 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified CSF-I. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. CSF-I was purified from medium conditioned by MIA PaCa-2 (ATCC CRL-1420). |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human colony stimulating factor subclass I (CSF-I) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human colony stimulating factor subclass I (CSF-I) |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in pristane primed BALB/c mice |
| Comments： | Animals were immunized with purified CSF-I. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. CSF-I was purified from medium conditioned by MIA PaCa-2 (ATCC CRL-1420). |
| Complete Growth Medium： | Culture Medium: Iscoves modified Dulbeccos medium, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: Twice per week Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp4 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG1 |
| Name of Depositor： | Amgen, Inc. |
| U.S. Patent Number： | |
| References： | Nicolson M. Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1. US Patent 4,504,586 dated Mar 12 1985 . . Hybridoma 2: 137, 1983. |
